US09073M1045
US09073M1045
Bio-Techne Corp
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.36B EUR | 11.03B EUR | 8.18B EUR | 9.17B EUR |
Enterprise Value | 11.39B EUR | 11.05B EUR | 8.26B EUR | 9.35B EUR |
Valuation Multiples | ||||
Trailing P/E | 62.47x | 60.64x | 74.66x | 156.66x |
Forward P/E | 31.33x | -- | -- | -- |
Price to Sales | 9.35x | 9.08x | 6.76x | 10.19x |
Price to Book | 5.37x | 5.23x | 3.92x | 4.56x |
EV/Revenue | 9.37x | 9.1x | 6.82x | 10.39x |
EV/EBITDA | 34.08x | 31.79x | 32.12x | 58.64x |
Price to FCF (P/FCF) | 49.48x | 41.9x | 30.34x | 47.74x |
EV/FCF | 49.58x | 41.99x | 30.64x | 48.67x |
FCF Yield | 2.02% | 2.39% | 3.3% | 2.09% |